MBE Wealth Management
ABBV icon

MBE Wealth Management’s AbbVie ABBV Stock Holding History

MBE Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41M Sell
5,392
-32
-0.6% -$8.2K 0.5% 32
2026
Q2 		$1.36M Sell
5,424
-41
-0.8% -$8.82K 0.48% 33
2026
Q1 		$1.19M Buy
5,465
+70
+1% +$15.5K 0.49% 33
2025
Q4 		$1.23M Sell
5,395
-24
-0.4% -$5.47K 0.52% 32
2025
Q3 		$1.25M Buy
5,419
+225
+4% +$45.8K 0.54% 31
2025
Q2 		$964K Buy
5,194
+2
+0% +$372 0.42% 34
2025
Q1 		$1.09M Buy
5,192
+244
+5% +$47.4K 0.52% 30
2024
Q4 		$879K Sell
4,948
-567
-10% -$104K 0.5% 29
2024
Q3 		$1.09M Buy
5,515
+1
+0% +$187 0.6% 28
2024
Q2 		$946K Sell
5,514
-140
-2% -$23.2K 0.57% 29
2024
Q1 		$1.03M Sell
5,654
-2,223
-28% -$383K 0.64% 26
2023
Q4 		$1.22M Buy
7,877
+1
+0% +$146 0.62% 21
2023
Q3 		$1.17M Buy
7,876
+1
+0% +$147 0.67% 19
2023
Q2 		$1.06M Buy
7,875
+478
+6% +$70.1K 0.57% 25
2023
Q1 		$1.18M Sell
7,397
-234
-3% -$35.8K 0.69% 19
2022
Q4 		$1.23M Buy
7,631
+2,907
+62% +$446K 0.8% 16
2022
Q3 		$634K Sell
4,724
-300
-6% -$43K 0.46% 22
2022
Q2 		$769K Sell
5,024
-141
-3% -$21.5K 0.54% 20
2022
Q1 		$837K Hold
5,165
– – 0.5% 21
2021
Q4 		$699K Buy
5,165
+42
+0.8% +$4.96K 0.36% 23
2021
Q3 		$553K Buy
5,123
+119
+2% +$13.6K 0.28% 22
2021
Q2 		$564K Buy
5,004
+92
+2% +$10.4K 0.29% 24
2021
Q1 		$532K Sell
4,912
-219
-4% -$23.4K 0.29% 33
2020
Q4 		$549K Buy
5,131
+296
+6% +$28.4K 0.37% 30
2020
Q3 		$474K Hold
4,835
– – 0.4% 27
2020
Q2 		$474K Buy
4,835
+3,952
+448% +$348K 0.4% 27
2020
Q1 		$67K Buy
+883
New +$75.2K 0.06% 94

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

MBE Wealth Management's ABBV Position: Q3 2026 in Review

MBE Wealth Management reduced its AbbVie (ABBV) stake by 0.59% in Q3 2026, selling an estimated $8.2K and leaving 5,392 shares worth $1.41M. The position accounts for 0.5% of the portfolio, ranked #32.

MBE Wealth Management first reported a position in ABBV in Q1 2020 and has held it in 27 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • MBE Wealth Management held 5,392 shares of AbbVie worth $1.41M as of Q3 2026.
  • MBE Wealth Management sold 32 AbbVie shares in Q3 2026, an estimated $8.2K.
  • AbbVie made up 0.5% of MBE Wealth Management's portfolio in Q3 2026, its #32 holding.
  • MBE Wealth Management first reported a position in AbbVie in Q1 2020 and has held it in 27 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MBE Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.